Monoclonal antibody to cytokeratin for use in routine histopathology - PubMed (original) (raw)

Monoclonal antibody to cytokeratin for use in routine histopathology

C A Makin et al. J Clin Pathol. 1984 Sep.

Abstract

CAM 5.2 is a murine monoclonal antibody, raised against the colon carcinoma cell line HT29, which recognises lower molecular weight intracellular cytokeratin proteins within secretory epithelia. Extensive indirect immunohistochemical studies have confirmed that this antibody stains formalin fixed (and freshly frozen) normal and malignant human tissue in a consistent manner. Reliable staining of conventionally processed pathological tissues provides more accurate identification and staging of human malignant epithelial diseases.

PubMed Disclaimer

Similar articles

• Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
  Liao SK, Horton L, Flahart RE, O'Rear L, Crumpacker D, Imbaratto JW, Yannelli JR, Robinson RR, Oldham RK. Liao SK, et al. Hum Antibodies Hybridomas. 1990;1(2):66-76. Hum Antibodies Hybridomas. 1990. PMID: 2103354
• Rat antikeratin monoclonal antibodies are specific for stratified squamous epithelia.
  Chin NW, Lai BT, Lanks KW. Chin NW, et al. Am J Clin Pathol. 1988 Mar;89(3):315-20. doi: 10.1093/ajcp/89.3.315. Am J Clin Pathol. 1988. PMID: 2450450
• Monoclonal antibodies to human colon and colorectal carcinoma.
  Thompson CH, Jones SL, Pihl E, McKenzie IF. Thompson CH, et al. Br J Cancer. 1983 May;47(5):595-605. doi: 10.1038/bjc.1983.97. Br J Cancer. 1983. PMID: 6342646 Free PMC article.
• Monoclonal antibody studies of mammalian epithelial keratins: a review.
  Sun TT, Tseng SC, Huang AJ, Cooper D, Schermer A, Lynch MH, Weiss R, Eichner R. Sun TT, et al. Ann N Y Acad Sci. 1985;455:307-29. doi: 10.1111/j.1749-6632.1985.tb50419.x. Ann N Y Acad Sci. 1985. PMID: 2417518 Review. No abstract available.
• Immunohistochemistry with enzyme labeled antibodies: a brief review.
  Farr AG, Nakane PK. Farr AG, et al. J Immunol Methods. 1981;47(2):129-44. doi: 10.1016/0022-1759(81)90114-9. J Immunol Methods. 1981. PMID: 6172519 Review. No abstract available.

Cited by

• Immunohistochemical Analyses of Mammalian Target of Rapamycin (mTOR) Expression in Pituitary Neuroendocrine Tumors (PitNETs): mTOR as a Therapeutic Target for Functional PitNETs.
  Nakazato I, Shiomi T, Oyama K, Matsuno A, Inomoto C, Yoshiyuki Osamura R. Nakazato I, et al. Acta Histochem Cytochem. 2023 Dec 28;56(6):121-126. doi: 10.1267/ahc.23-00039. Epub 2023 Dec 20. Acta Histochem Cytochem. 2023. PMID: 38318106 Free PMC article.
• Laparoscopic Peritoneal Wash Cytology-Derived Primary Human Mesothelial Cells for In Vitro Cell Culture and Simulation of Human Peritoneum.
  Holl M, Becker L, Keller AL, Feuerer N, Marzi J, Carvajal Berrio DA, Jakubowski P, Neis F, Pauluschke-Fröhlich J, Brucker SY, Schenke-Layland K, Krämer B, Weiss M. Holl M, et al. Biomedicines. 2021 Feb 10;9(2):176. doi: 10.3390/biomedicines9020176. Biomedicines. 2021. PMID: 33578986 Free PMC article.
• Intermediate filament protein expression and mesoderm formation in the rabbit embryo : A double-labelling immunofluorescence study.
  Viebahn C, Lane EB, Ramaekers FC. Viebahn C, et al. Rouxs Arch Dev Biol. 1992 Feb;201(1):45-60. doi: 10.1007/BF00188775. Rouxs Arch Dev Biol. 1992. PMID: 28305611
• Management of aggressive growth hormone secreting pituitary adenomas.
  Donoho DA, Bose N, Zada G, Carmichael JD. Donoho DA, et al. Pituitary. 2017 Feb;20(1):169-178. doi: 10.1007/s11102-016-0781-7. Pituitary. 2017. PMID: 27987061 Review.
• Cavernosal nerve functionality evaluation after magnetic resonance imaging-guided transurethral ultrasound treatment of the prostate.
  Sammet S, Partanen A, Yousuf A, Sammet CL, Ward EV, Wardrip C, Niekrasz M, Antic T, Razmaria A, Farahani K, Sokka S, Karczmar G, Oto A. Sammet S, et al. World J Radiol. 2015 Dec 28;7(12):521-30. doi: 10.4329/wjr.v7.i12.521. World J Radiol. 2015. PMID: 26753067 Free PMC article.

References

1. 1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
2. 1. Lab Invest. 1983 Sep;49(3):353-61 - PubMed
3. 1. Cancer Res. 1976 Dec;36(12):4562-9 - PubMed
4. 1. J Natl Cancer Inst. 1977 May;58(5):1507-12 - PubMed
5. 1. J Exp Med. 1977 Nov 1;146(5):1261-79 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations